PURCHASE, N.Y. - (Business Wire) IntegraMed America, Inc. (NASDAQ: INMD), the leading operator of fertility centers and vein clinics in the United States, today announced healthcare executive Dan P. Doman, CPA, has been promoted to President of its Vein Clinics of America (VCA) division, effective May 15, 2008. Mr. Doman replaces Kush Agarwal, who has retired from the role but will continue to serve as a member of the IntegraMed Board of Directors.
Doman, who has served as Chief Financial Officer of VCA since April 2006, has a demonstrated track record of success in healthcare management and finance over the past 24 years. His appointment as President comes at an exciting time, as VCA has extended its business platform and personnel to support accelerated expansion for the Vein Clinics business.
“Dan’s knowledge, experience, and record of accomplishment will help lead VCA through its next stage of growth and development,” commented Jay Higham, IntegraMed President and CEO. “We conducted a nationwide search led by a top executive recruiting firm to find an ideal candidate with a strong track record of health care experience. Dan completed the same process as all of the external candidates, but in the final analysis, Dan’s unique skill sets made him the strongest candidate to lead VCA.
“We also want to acknowledge Kush’s valuable leadership to VCA throughout the years, including his efforts in the past ten months to integrate VCA with IntegraMed and to solidify the foundation and pathway for growth,” continued Mr. Higham. “He has served as President and CEO of Vein Clinics of America for 21 years and was a driving force behind the company's growth from a few clinics to 30 today. Kush was instrumental in developing the operating model and corporate structure that is VCA.”
Before joining VCA, Doman was for three years a Managing Director at Health Dimension Group, a national integrated senior-living and healthcare management and consulting firm in Minneapolis. His responsibilities included financial and operational feasibility analysis. From 1993 through 2003 Mr. Doman was at BDO Seidman, LLP, where he rose over that period to the position of Partner-in-Charge, Chicago Healthcare Practice. His responsibilities included being the national specialist on matters of Medicare and Medicaid reimbursement for healthcare providers. Prior to BDO, Mr. Doman’s work experience included increasing levels of responsibility with Horizon Health Corporation and Chicago Holy Cross Hospital. Mr. Doman graduated from Loyola University of Chicago in 1984 with a B.B.A. in accounting and finance.
About IntegraMed America, Inc.
IntegraMed America, Inc. is the leading operator of fertility centers and vein care clinics in the United States. The Company supports its provider networks with state-of-the art information systems; marketing and payer contracting; financial planning, reporting and analysis; organizational planning and development; quality assurance initiatives; human resources administration; and purchasing services. IntegraMed also offers consumer treatment-financing programs and operates www.integramed.com, a leading fertility portal.
The IntegraMed Fertility network consists of 31 contracted centers in 101 locations across the United States, including 171 physicians and Ph.D. scientists. One of every five IVF procedures in the U.S. is performed in an IntegraMed fertility practice. The IntegraMed Vein Clinic network is the leading provider of vein care services in the US and operates 30 centers in 11 states, principally in the Midwest and Southeast.
Statements contained in this press release that are not based on historical fact, including statements concerning future results, performance, expectations and expansion of IntegraMed are forward-looking statements that may involve a number of risks and uncertainties. Actual results may differ materially from the statements made as a result of various factors, including, but not limited to, the risks associated with IntegraMed's ability to finance future growth; changes in insurance coverage, government laws and regulations regarding health care or managed care contracting; and other risks, including those identified in the company's most recent Form 10-K and in other documents filed by IntegraMed with the U.S. Securities and Exchange Commission. All information in this press release is as of May 16, 2008 and IntegraMed undertakes no duty to update this information.
Investors:
IntegraMed America, Inc.
John W. Hlywak, Jr., EVP and CFO, 914-251-4143
jhlywak@integramed.com
or
Media/Investors:
Jaffoni & Collins Incorporated
Steven Hecht, David Collins
212-835-8500
inmd@jcir.com
